The distinct pathway enrichment profiles and our survival and alteration frequency analyses presented above support a context‐dependent role for DMD (and most notably, the Dp71ab gene product) in cancer, which reconciles conflicting reports of its oncogenic versus tumour‐suppressive functions. This evidence concerns the gene DMD and neoplasm.